387 related articles for article (PubMed ID: 36597861)
1. Recent advances in genetic tools for engineering probiotic lactic acid bacteria.
Mugwanda K; Hamese S; Van Zyl WF; Prinsloo E; Du Plessis M; Dicks LMT; Thimiri Govinda Raj DB
Biosci Rep; 2023 Jan; 43(1):. PubMed ID: 36597861
[TBL] [Abstract][Full Text] [Related]
2. Portable CRISPR-Cas9
Goh YJ; Barrangou R
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas systems of lactic acid bacteria and applications in food science.
Cui Y; Qu X
Biotechnol Adv; 2024; 71():108323. PubMed ID: 38346597
[TBL] [Abstract][Full Text] [Related]
4. Genetic tools for the development of recombinant lactic acid bacteria.
Wu J; Xin Y; Kong J; Guo T
Microb Cell Fact; 2021 Jun; 20(1):118. PubMed ID: 34147119
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-Assisted Seamless Genome Editing in Lactobacillus plantarum and Its Application in
Zhou D; Jiang Z; Pang Q; Zhu Y; Wang Q; Qi Q
Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444197
[No Abstract] [Full Text] [Related]
6. Genetic engineering as a powerful tool to improve probiotic strains.
Bravo D; Landete JM
Biotechnol Genet Eng Rev; 2017 Oct; 33(2):173-189. PubMed ID: 29192561
[TBL] [Abstract][Full Text] [Related]
7. Engineering Kluyveromyces marxianus as a Robust Synthetic Biology Platform Host.
Cernak P; Estrela R; Poddar S; Skerker JM; Cheng YF; Carlson AK; Chen B; Glynn VM; Furlan M; Ryan OW; Donnelly MK; Arkin AP; Taylor JW; Cate JHD
mBio; 2018 Sep; 9(5):. PubMed ID: 30254120
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas-mediated gene editing in lactic acid bacteria.
Song X; Zhang XY; Xiong ZQ; Liu XX; Xia YJ; Wang SJ; Ai LZ
Mol Biol Rep; 2020 Oct; 47(10):8133-8144. PubMed ID: 32926267
[TBL] [Abstract][Full Text] [Related]
9. Engineering Synthetic Gene Circuits in Living Cells with CRISPR Technology.
Jusiak B; Cleto S; Perez-Piñera P; Lu TK
Trends Biotechnol; 2016 Jul; 34(7):535-547. PubMed ID: 26809780
[TBL] [Abstract][Full Text] [Related]
10. Renaissance of traditional DNA transfer strategies for improvement of industrial lactic acid bacteria.
Bron PA; Marcelli B; Mulder J; van der Els S; Morawska LP; Kuipers OP; Kok J; Kleerebezem M
Curr Opin Biotechnol; 2019 Apr; 56():61-68. PubMed ID: 30317145
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances of CRISPR/Cas9-Based Genetic Engineering and Transcriptional Regulation in Industrial Biology.
Zhang S; Guo F; Yan W; Dai Z; Dong W; Zhou J; Zhang W; Xin F; Jiang M
Front Bioeng Biotechnol; 2019; 7():459. PubMed ID: 32047743
[TBL] [Abstract][Full Text] [Related]
12. Advanced probiotics: bioengineering and their therapeutic application.
Parvin T; Sadras SR
Mol Biol Rep; 2024 Feb; 51(1):361. PubMed ID: 38403783
[TBL] [Abstract][Full Text] [Related]
13. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
14. Engineering Tools for the Development of Recombinant Lactic Acid Bacteria.
Cho SW; Yim J; Seo SW
Biotechnol J; 2020 Jun; 15(6):e1900344. PubMed ID: 31995278
[TBL] [Abstract][Full Text] [Related]
15. Efficient and Scalable Precision Genome Editing in
Penewit K; Holmes EA; McLean K; Ren M; Waalkes A; Salipante SJ
mBio; 2018 Feb; 9(1):. PubMed ID: 29463653
[No Abstract] [Full Text] [Related]
16. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
[No Abstract] [Full Text] [Related]
17. Synthetic biology in probiotic lactic acid bacteria: At the frontier of living therapeutics.
Mays ZJ; Nair NU
Curr Opin Biotechnol; 2018 Oct; 53():224-231. PubMed ID: 29550614
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in genetic engineering tools based on synthetic biology.
Ren J; Lee J; Na D
J Microbiol; 2020 Jan; 58(1):1-10. PubMed ID: 31898252
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
Bober JR; Beisel CL; Nair NU
Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
Dey A
Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
